GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Francesca Bonifazi, Nicolaus Kröger, Christine Wolschke et al.|The Lancet Haematology|2019

Cited by 58